Rani Therapeutics Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RANI research report →
About the company
Rani Therapeutics Holdings, Inc. functions as a clinical-stage biopharmaceutical enterprise focused on revolutionizing the delivery of biologic therapies through oral administration. Its flagship innovation, the RaniPill capsule, aims to supplant conventional subcutaneous or intravenous injections of biologics with a more convenient oral dosing method.
- CEO
- Talat Imran
- IPO
- 2021
- Employees
- 105
- HQ
- San Jose, CA, US
Price Chart
- Market Cap
- $50.38M
- P/E
- -1.89
- P/S
- 15.90
- P/B
- 4.89
- EV/EBITDA
- -1.34
- Div Yield
- 0.00%
- Gross Margin
- 94.92%
- Op Margin
- -1092.96%
- Net Margin
- -929.06%
- ROE
- -245.45%
- ROIC
- -87.72%
- Revenue
- $1.63M · 58.85%
- Net Income
- $-29,673,000 · 1.15%
- EPS
- $-0.45 · 57.14%
- Op Income
- $-38,310,000
- FCF YoY
- 47.43%
- 52W High
- $3.87
- 52W Low
- $0.39
- 50D MA
- $0.89
- 200D MA
- $1.18
- Beta
- 0.76
- Avg Volume
- 882.00K
Get TickerSpark's AI analysis on RANI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 26 | McKinley Kate | other | 805,500 |
| Jun 3, 26 | Javadi Alireza | other | 805,500 |
| Jun 3, 26 | Imran Talat | other | 3,800,000 |
| May 28, 26 | Bassan Abraham | other | 123,600 |
| May 28, 26 | Rometty Lisa Ann | other | 123,600 |
| May 28, 26 | IMRAN MIR A | other | 123,600 |
| May 28, 26 | BUTEL JEAN LUC | other | 123,600 |
| May 28, 26 | Bailey Vasudev Jaiprakash | other | 123,600 |
| May 28, 26 | Ausiello Dennis A | other | 123,600 |
| Mar 18, 26 | Javadi Alireza | other | 0 |
Our RANI coverage
Recent articles, reports, and earnings notes.
No research on RANI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RANI report →Similar companies
Peers in the same neighborhood.